Correlation Between Vaxcyte and Ventyx Biosciences

Can any of the company-specific risk be diversified away by investing in both Vaxcyte and Ventyx Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaxcyte and Ventyx Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vaxcyte and Ventyx Biosciences, you can compare the effects of market volatilities on Vaxcyte and Ventyx Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaxcyte with a short position of Ventyx Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaxcyte and Ventyx Biosciences.

Diversification Opportunities for Vaxcyte and Ventyx Biosciences

0.25

Correlation Coefficient

Vaxcyte  Ventyx Biosciences

Modest diversification

The 3 months correlation between Vaxcyte and Ventyx is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Vaxcyte and Ventyx Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ventyx Biosciences and Vaxcyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaxcyte are associated (or correlated) with Ventyx Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ventyx Biosciences has no effect on the direction of Vaxcyte i.e., Vaxcyte and Ventyx Biosciences go up and down completely randomly.

Pair Corralation between Vaxcyte and Ventyx Biosciences

Given the investment horizon of 90 days Vaxcyte is expected to generate 0.25 times more return on investment than Ventyx Biosciences. However, Vaxcyte is 3.93 times less risky than Ventyx Biosciences. It trades about 0.19 of its potential returns per unit of risk. Ventyx Biosciences is currently generating about -0.08 per unit of risk. If you would invest  6,557  in Vaxcyte on March 10, 2024 and sell it today you would earn a total of  694.00  from holding Vaxcyte or generate 10.58% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	95.45%
Values	Daily Returns

Vaxcyte  vs.  Ventyx Biosciences

Vaxcyte

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Vaxcyte are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Vaxcyte is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Ventyx Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ventyx Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in July 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Vaxcyte and Ventyx Biosciences

The main advantage of trading using opposite Vaxcyte and Ventyx Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaxcyte position performs unexpectedly, Ventyx Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ventyx Biosciences will offset losses from the drop in Ventyx Biosciences' long position.

The idea behind Vaxcyte and Ventyx Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.